Free Trial

Coya Therapeutics (COYA) Insider Trading & Ownership

Coya Therapeutics logo
$5.24 +0.08 (+1.55%)
(As of 12/20/2024 05:31 PM ET)

Coya Therapeutics (NASDAQ:COYA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.00%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$69,614.70
Number Of
Insiders Selling
(Last 12 Months)
0
Get COYA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

COYA Insider Buying and Selling by Quarter

Coya Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2024David S SnyderCFOBuy1,800$7.19$12,942.00  
11/11/2024Arun SwaminathanCEOBuy5,000$7.34$36,700.00  
11/11/2024Fred GrossmanInsiderBuy2,710$7.37$19,972.70  
(Data available from 1/1/2013 forward)

COYA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Coya Therapeutics includes Arun Swaminathan, David S Snyder, and Fred Grossman. Learn more on insiders at COYA.

12.00% of Coya Therapeutics stock is owned by insiders. Learn more on COYA's insider holdings.

The following insiders have purchased COYA shares in the last 24 months: Arun Swaminathan ($36,700.00), David S Snyder ($12,942.00), and Fred Grossman ($19,972.70).

Insiders have purchased a total of 9,510 COYA shares in the last 24 months for a total of $69,614.70 bought.

Coya Therapeutics Key Executives

  • Dr. Howard Berman Ph.D. (Age 50)
    Chairman & CEO
    Compensation: $833.75k
  • Dr. Fred Grossman D.O. (Age 62)
    FAPA, President & Chief Medical Officer
    Compensation: $610.63k
  • Mr. David S. Snyder (Age 64)
    CFO & COO
    Compensation: $610.94k
    1 recent trades
  • Dr. Gregory MacMichael Ph.D. (Age 68)
    Chief Technical Officer
  • Dr. Michelle Frazier Ph.D.
    Senior Vice President of Regulatory Affairs
  • Mr. Aaron Thome Ph.D.
    Head of Neuroinflammation Platform
  • Dr. Arun Swaminathan Ph.D.
    Chief Business Development Officer


This page (NASDAQ:COYA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners